Marker Name |
Phenotype |
Related Gene |
Marker's Category |
Reference |
rs1021356
|
PTSD |
|
Trend |
Logue, M. W.,2013
|
rs113508478
|
PTSD |
|
Trend |
Logue, M. W.,2013
|
rs12118091
|
PTSD |
|
Trend |
Logue, M. W.,2013
|
rs9923585
|
Lifetime PTSD |
ABCC1 |
Trend |
Xie, P.,2013
|
rs10170218
|
PTSD |
AC068718.1 |
Significant |
Guffanti, G.,2013
|
rs263232
|
Dissociative symptom severity |
ADCY8 |
Trend |
Wolf, E. J.,2014
|
rs263234
|
Dissociative symptom severity |
ADCY8 |
Non-significant |
Wolf, E. J.,2014
|
rs263238
|
Dissociative symptom severity |
ADCY8 |
Non-significant |
Wolf, E. J.,2014
|
rs4339660
|
Dissociative symptom severity |
ADCY8 |
Non-significant |
Wolf, E. J.,2014
|
rs7015079
|
Dissociative symptom severity |
ADCY8 |
Non-significant |
Wolf, E. J.,2014
|
rs2267735
|
Chronic PTSD |
ADCYAP1 |
Non-significant |
Chang, S. C.,2012
|
rs2267735
|
Total number of PTSD symptoms |
ADCYAP1 |
Non-significant |
Chang, S. C.,2012
|
rs2267735
|
Current PTSD |
ADCYAP1 |
Non-significant |
Chang, S. C.,2012
|
rs2267735
|
PTSD symptom severity |
ADCYAP1 |
Non-significant |
Chang, S. C.,2012
|
rs2267735
|
PTSD symptom subscale scores |
ADCYAP1 |
Non-significant |
Chang, S. C.,2012
|
rs2267735
|
PTSD |
ADCYAP1 |
Non-significant |
Chang, S. C.,2012
|
rs2267735
|
Avoidance symptoms |
ADCYAP1R1 |
Non-significant |
Wang, L.,2013
|
rs2267735
|
PTSD symptoms at week 4 |
ADCYAP1R1 |
Non-significant |
Rothbaum, B. O.,2014
|
rs2267735
|
Reexperiencing symptoms |
ADCYAP1R1 |
Non-significant |
Wang, L.,2013
|
rs2267735
|
Dark enhanced startle |
ADCYAP1R1 |
Significant |
Ressler, K. J.,2011
|
rs2267735
|
Diagnosis of PTSD at week 12 |
ADCYAP1R1 |
Significant |
Rothbaum, B. O.,2014
|
rs6968349
|
PTSD |
ADCYAP1R1 |
Significant |
Nievergelt, C. M.,2015
|
rs2267735
|
Dysphoric arousal symptoms |
ADCYAP1R1 |
Non-significant |
Wang, L.,2013
|
rs2267735
|
Emotional numbing symptoms |
ADCYAP1R1 |
Significant |
Wang, L.,2013
|
rs2267735
|
Fear Discrimination |
ADCYAP1R1 |
Significant |
Ressler, K. J.,2011
|
rs10081254
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs10226318
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Solovieff, N.,2014
|
rs10241138
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs10268647
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs10269014
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs10277350
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs11979764
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs12670977
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs12670991
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs1541516
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs1541518
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs17159861
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs17723231
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs1981701
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs2041568
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs2267735
|
Past month PTS severity |
ADCYAP1R1 |
Non-significant |
Uddin, M.,2013
|
rs2267735
|
Past month PTSD |
ADCYAP1R1 |
Non-significant |
Uddin, M.,2013
|
rs2267727
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs2267733
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs2267735
|
PTSD diagnosis |
ADCYAP1R1 |
Significant |
Ressler, K. J.,2011
|
rs2267737
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs2267738
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs2267740
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs4503014
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs741051
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs7784067
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs7786118
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs7804302
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs7804958
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs2267735
|
PSS hyperarousal score |
ADCYAP1R1 |
Significant |
Ressler, K. J.,2011
|
rs7805043
|
PTSD diagnosis |
ADCYAP1R1 |
Non-significant |
Ressler, K. J.,2011
|
rs2267735
|
PSS total score |
ADCYAP1R1 |
Significant |
Ressler, K. J.,2011
|
rs2284225
|
PTSD severity |
ADCYAP1R1 |
Non-significant |
Solovieff, N.,2014
|
rs2267735
|
PTSD symptom severity |
ADCYAP1R1 |
Non-significant |
Almli, L. M.,2013
|
rs2267735
|
PTSD symptoms |
ADCYAP1R1 |
Non-significant |
Wang, L.,2013
|
rs2267735
|
Anxious arousal symptoms |
ADCYAP1R1 |
Non-significant |
Wang, L.,2013
|
rs74939664
|
PTSD |
ADGRL2 |
Trend |
Nievergelt, C. M.,2015
|
rs2400707
|
PTSD diagnosis |
ADRB2 |
Non-significant |
Hauser, M. A.,2017
|
rs6969903
|
Lifetime PTSD |
AHR |
Trend |
Xie, P.,2013
|
rs4430311
|
Lifetime PTSD |
AKT3 |
Trend |
Xie, P.,2013
|
rs28932171
|
PTSD |
ANK3 |
Significant |
Logue, M. W.,2013
|
rs7098848
|
PTSD |
ANK3 |
Significant |
Logue, M. W.,2013
|
rs72818458
|
PTSD |
ANK3 |
Significant |
Logue, M. W.,2013
|
rs7917800
|
PTSD |
ANK3 |
Significant |
Logue, M. W.,2013
|
rs9804190
|
PTSD |
ANK3 |
Significant |
Logue, M. W.,2013
|
rs1049862
|
PTSD |
ANK3 |
Non-significant |
Logue, M. W.,2013
|
rs10821659
|
PTSD |
ANK3 |
Non-significant |
Logue, M. W.,2013
|
rs11599164
|
PTSD |
ANK3 |
Significant |
Logue, M. W.,2013
|
rs11599447
|
PTSD |
ANK3 |
Significant |
Logue, M. W.,2013
|
rs11813307
|
PTSD |
ANK3 |
Non-significant |
Logue, M. W.,2013
|
rs12357206
|
PTSD |
ANK3 |
Non-significant |
Logue, M. W.,2013
|
rs1049862 - rs12357206 - rs10821659 - rs11813307, GGAA
|
PTSD |
ANK3 |
Non-significant |
Logue, M. W.,2013
|
rs139604943
|
PTSD |
ANK3 |
Significant |
Nievergelt, C. M.,2015
|
rs17208576
|
PTSD |
ANK3 |
Significant |
Logue, M. W.,2013
|
rs72818458 - rs28932171 - rs11599164 - rs17208576 - rs9804190 - rs7917800 - rs7098848, AGAAAAG
|
PTSD |
ANK3 |
Significant |
Logue, M. W.,2013
|
rs159572
|
PTSD diagnosis |
ANKRD55 |
Significant |
Stein, M. B.,2016
|
APOB_intron_2-21091512
|
Lifetime PTSD |
APOB |
Trend |
Xie, P.,2013
|
rs584007
|
PTSD diagnosis |
APOE |
Non-significant |
Solovieff, N.,2014
|
APOE_euro2/euro3/euro4
|
PTSD |
APOE |
Significant |
Kim, T. Y.,2013
|
APOE_euro4
|
PTSD diagnosis |
APOE |
Non-significant |
Lyons, M. J.,2013
|
APOE_euro4
|
PTSD symptomatology |
APOE |
Significant |
Lyons, M. J.,2013
|
rs1081105
|
PTSD |
APOE |
Non-significant |
Nievergelt, C. M.,2015
|
rs584007
|
PTSD severity |
APOE |
Non-significant |
Solovieff, N.,2014
|
rs7929974
|
PTSD |
ARRB1 |
Non-significant |
Nelson, E. C.,2014
|
rs6265
|
CAPS score |
BDNF |
Non-significant |
Bruenig, D.,2016
|
rs6265
|
PTSD |
BDNF |
Non-significant |
Zhang, H.,2006
|
rs6265
|
PTSD |
BDNF |
Non-significant |
Valente, N. L.,2011
|
rs6265
|
PTSD |
BDNF |
Non-significant |
Wang, T.,2015
|
rs6265
|
PTSD |
BDNF |
Non-significant |
Lee, Heon-Jeong,2006
|
rs6265
|
Changes in PTSD severity between 6 and 12 months |
BDNF |
Non-significant |
Li, R. H.,2016
|
rs6265
|
Changes in PTSD severity between 6 and 18 months |
BDNF |
Non-significant |
Li, R. H.,2016
|
rs6265
|
Changes in PTSD severity between 12 and 18 months |
BDNF |
Significant |
Li, R. H.,2016
|
rs6265
|
PCL-C Scores of the Subjects with Different Genotypes of BDNF Val66Met at 6 or 12 or 18 Months After the Earthquake |
BDNF |
Significant |
Li, R. H.,2016
|
rs2140887
|
PTSD diagnosis |
BDNF |
Non-significant |
Solovieff, N.,2014
|
rs6265
|
PTSD diagnosis |
BDNF |
Non-significant |
van den Heuvel, L.,2016
|
rs6265
|
CAPS score |
BDNF |
Non-significant |
van den Heuvel, L.,2016
|
rs6265
|
Post Traumatic Growth (PTG) |
BDNF |
Non-significant |
Dunn, E. C.,2014
|
rs6265
|
Post-traumatic stress symptoms (PTS) |
BDNF |
Non-significant |
Dunn, E. C.,2014
|
rs6265
|
Prevalence of PTSD in the Subjects with Different BDNF Val66Met Genotypes at 6 or 12 or 18 Months After the Earthquake |
BDNF |
Significant |
Li, R. H.,2016
|
rs6265
|
Psychotic symptoms in PTSD |
BDNF |
Significant |
Pivac, N.,2012
|
BDNF_5'region_G712A
|
PTSD |
BDNF |
Non-significant |
Zhang, H.,2006
|
BDNF_exon_C270T
|
PTSD |
BDNF |
Non-significant |
Zhang, H.,2006
|
rs1464896
|
PTSD severity |
BDNF |
Non-significant |
Solovieff, N.,2014
|
G-712A-C270T-Val66Met, G-C-A,G-C-G,G-T-G,A-C-G,A-T-A,A-T-G
|
Posttraumatic Stress Disorder |
BDNF |
Non-significant |
Zhang, H.,2006
|
rs6265
|
PTSD symptoms |
BDNF |
Non-significant |
La Greca, A. M.,2013
|
rs71355256
|
PTSD |
C17orf97 |
Trend |
Logue, M. W.,2013
|
rs1500899
|
Lifetime PTSD |
C8orf37 |
Trend |
Xie, P.,2013
|
rs1006737
|
Post Traumatic Growth (PTG) |
CACNA1C |
Non-significant |
Dunn, E. C.,2014
|
rs1006737
|
Post-traumatic stress symptoms (PTS) |
CACNA1C |
Non-significant |
Dunn, E. C.,2014
|
rs10836233
|
PTSD diagnosis |
CAT |
Non-significant |
Duan, Z. X.,2014
|
rs208679
|
PTSD diagnosis |
CAT |
Non-significant |
Duan, Z. X.,2014
|
rs2300182
|
PTSD diagnosis |
CAT |
Non-significant |
Duan, Z. X.,2014
|
rs7104301
|
PTSD diagnosis |
CAT |
Non-significant |
Duan, Z. X.,2014
|
rs769217
|
PTSD diagnosis |
CAT |
Non-significant |
Duan, Z. X.,2014
|
rs7949972
|
PTSD diagnosis |
CAT |
Non-significant |
Duan, Z. X.,2014
|
rs208679 - rs10836233 - rs2300182 - rs769217 - rs7104301 - rs7949972, AAACAC
|
PTSD diagnosis |
CAT |
Non-significant |
Duan, Z. X.,2014
|
rs208679 - rs10836233 - rs2300182 - rs769217 - rs7104301 - rs7949972, AATCAC
|
PTSD diagnosis |
CAT |
Significant |
Duan, Z. X.,2014
|
rs208679 - rs10836233 - rs2300182 - rs769217 - rs7104301 - rs7949972 ,AGTCAC
|
PTSD diagnosis |
CAT |
Non-significant |
Duan, Z. X.,2014
|
rs208679 - rs10836233 - rs2300182 - rs769217 - rs7104301 - rs7949972, AGTTAT
|
PTSD diagnosis |
CAT |
Significant |
Duan, Z. X.,2014
|
rs208679 - rs10836233 - rs2300182 - rs769217 - rs7104301 - rs7949972, GGTTGT
|
PTSD diagnosis |
CAT |
Non-significant |
Duan, Z. X.,2014
|
rs1799923
|
PTSD diagnosis |
CCK |
Significant |
Badour, C. L.,2015
|
rs60646603
|
PTSD |
CHRNA2 |
Significant |
Kimbrel, N. A.,2015
|
rs73679204
|
PTSD |
CHRNA2 |
Significant |
Kimbrel, N. A.,2015
|
rs10104133
|
PTSD |
CHRNA2 |
Non-significant |
Kimbrel, N. A.,2015
|
rs2565067
|
PTSD |
CHRNA2 |
Non-significant |
Kimbrel, N. A.,2015
|
rs62516743
|
PTSD |
CHRNA3 |
Non-significant |
Kimbrel, N. A.,2015
|
rs75431302
|
PTSD |
CHRNA3 |
Non-significant |
Kimbrel, N. A.,2015
|
rs1316971
|
PTSD |
CHRNA4 |
Significant |
Kimbrel, N. A.,2015
|
rs518425
|
PTSD |
CHRNA5 |
Non-significant |
Nievergelt, C. M.,2015
|
rs588765
|
PTSD |
CHRNA5 |
Significant |
Kimbrel, N. A.,2015
|
rs80087508
|
PTSD |
CHRNA5 |
Significant |
Kimbrel, N. A.,2015
|
rs12898919
|
PTSD |
CHRNA5 |
Significant |
Kimbrel, N. A.,2015
|
rs16969968
|
PTSD |
CHRNA5 |
Non-significant |
Kimbrel, N. A.,2015
|
rs74572794
|
PTSD |
CHRNA6 |
Non-significant |
Kimbrel, N. A.,2015
|
rs8036584
|
PTSD |
CHRNA7 |
Significant |
Kimbrel, N. A.,2015
|
rs806377
|
PTSD diagnosis |
CNR1 |
Non-significant |
Solovieff, N.,2014
|
rs7766029
|
PTSD severity |
CNR1 |
Non-significant |
Solovieff, N.,2014
|
rs382903
|
Lifetime PTSD |
COBL |
Trend |
Xie, P.,2013
|
rs406001
|
Lifetime PTSD |
COBL |
Significant |
Xie, P.,2013
|
rs450378
|
Lifetime PTSD |
COBL |
Trend |
Xie, P.,2013
|
rs382903
|
PTSD symptoms (mPSS) |
COBL |
Non-significant |
Almli, L. M.,2014
|
rs406001
|
PTSD symptoms (mPSS) |
COBL |
Non-significant |
Almli, L. M.,2014
|
rs450378
|
PTSD symptoms (mPSS) |
COBL |
Non-significant |
Almli, L. M.,2014
|
rs4773155
|
PTSD Symptoms as measured by the quantitave CAPS scores |
COL4A2 |
Trend |
Almli, L. M.,2015
|
rs4633
|
B category score |
COMT |
Non-significant |
Goenjian, A. K.,2014
|
rs4680
|
B category score |
COMT |
Non-significant |
Goenjian, A. K.,2014
|
rs4818
|
B category score |
COMT |
Non-significant |
Goenjian, A. K.,2014
|
rs6269
|
B category score |
COMT |
Non-significant |
Goenjian, A. K.,2014
|
rs4633
|
C category score |
COMT |
Significant |
Goenjian, A. K.,2014
|
rs4680
|
C category score |
COMT |
Non-significant |
Goenjian, A. K.,2014
|
rs4818
|
C category score |
COMT |
Non-significant |
Goenjian, A. K.,2014
|
rs6269
|
C category score |
COMT |
Non-significant |
Goenjian, A. K.,2014
|
rs4680
|
CAPS scores |
COMT |
Significant |
Valente, N. L.,2011
|
rs4680
|
PTSD |
COMT |
Significant |
Valente, N. L.,2011
|
rs4633
|
Total PTSD symptom severity score |
COMT |
Significant |
Goenjian, A. K.,2014
|
rs4680
|
Total PTSD symptom severity score |
COMT |
Non-significant |
Goenjian, A. K.,2014
|
rs4818
|
Total PTSD symptom severity score |
COMT |
Non-significant |
Goenjian, A. K.,2014
|
rs6269
|
Total PTSD symptom severity score |
COMT |
Non-significant |
Goenjian, A. K.,2014
|
rs4680
|
Total PTSD symptoms |
COMT |
Significant |
Humphreys, K. L.,2014
|
rs4633
|
D category score |
COMT |
Significant |
Goenjian, A. K.,2014
|
rs4680
|
D category score |
COMT |
Non-significant |
Goenjian, A. K.,2014
|
rs4818
|
D category score |
COMT |
Non-significant |
Goenjian, A. K.,2014
|
rs6269
|
D category score |
COMT |
Non-significant |
Goenjian, A. K.,2014
|
rs9306235
|
Dissociative symptom severity |
COMT |
Non-significant |
Wolf, E. J.,2014
|
rs4680
|
PTSD category D symptom |
COMT |
Significant |
Humphreys, K. L.,2014
|
rs4680
|
Lifetime PTSD |
COMT |
Non-significant |
Kolassa, I. T.,2010
|
rs165774
|
PTSD diagnosis |
COMT |
Non-significant |
Solovieff, N.,2014
|
rs4680
|
PTSD diagnosis |
COMT |
Significant |
Winkler, E. A.,2017
|
rs4680
|
CAPS score |
COMT |
Non-significant |
Hayes, J. P.,2017
|
rs4680
|
PTSD symptom severity |
COMT |
Non-significant |
van Rooij, S. J.,2016
|
rs4680
|
PTSD intrusive symptoms |
COMT |
Non-significant |
van Rooij, S. J.,2016
|
rs4680
|
PTSD avoidance/numbing symptoms |
COMT |
Non-significant |
van Rooij, S. J.,2016
|
rs4680
|
PTSD hyperarousal symptoms |
COMT |
Non-significant |
van Rooij, S. J.,2016
|
rs4680
|
PTSD diagnosis |
COMT |
Non-significant |
Humphreys, K. L.,2014
|
rs165774
|
PTSD severity |
COMT |
Non-significant |
Solovieff, N.,2014
|
rs4680
|
PTSD symptoms (combined scores for severity and frequency) |
COMT |
Non-significant |
Clark, R.,2013
|
rs174686
|
PTSD |
COMT |
Significant |
Nievergelt, C. M.,2015
|
rs10055255
|
Post-ICU PTSD |
CRHBP |
Significant |
Davydow, D. S.,2014
|
rs12944712
|
Decline in PTSD symptoms |
CRHR1 |
Significant |
Amstadter, A. B.,2011
|
rs12944712
|
Post Traumatic Growth (PTG) |
CRHR1 |
Non-significant |
Dunn, E. C.,2014
|
rs242941
|
PTSD diagnosis |
CRHR1 |
Non-significant |
Solovieff, N.,2014
|
rs12938031
|
Post-hurricane PTSD diagnosis |
CRHR1 |
Significant |
White, S.,2013
|
rs4792887
|
Post-hurricane PTSD diagnosis |
CRHR1 |
Non-significant |
White, S.,2013
|
rs110402
|
Post-hurricane PTSD symptoms |
CRHR1 |
Non-significant |
White, S.,2013
|
rs12938031
|
Post-hurricane PTSD symptoms |
CRHR1 |
Significant |
White, S.,2013
|
rs16940686
|
Post-hurricane PTSD symptoms |
CRHR1 |
Non-significant |
White, S.,2013
|
rs171441
|
Post-hurricane PTSD symptoms |
CRHR1 |
Non-significant |
White, S.,2013
|
rs173365
|
Post-hurricane PTSD symptoms |
CRHR1 |
Significant |
White, S.,2013
|
rs17689966
|
Post-hurricane PTSD symptoms |
CRHR1 |
Significant |
White, S.,2013
|
rs242924
|
Post-hurricane PTSD symptoms |
CRHR1 |
Non-significant |
White, S.,2013
|
rs242936
|
Post-hurricane PTSD symptoms |
CRHR1 |
Non-significant |
White, S.,2013
|
rs242939
|
Post-hurricane PTSD symptoms |
CRHR1 |
Non-significant |
White, S.,2013
|
rs2664008
|
Post-hurricane PTSD symptoms |
CRHR1 |
Non-significant |
White, S.,2013
|
rs4792887
|
Post-hurricane PTSD symptoms |
CRHR1 |
Significant |
White, S.,2013
|
rs7209436
|
Post-hurricane PTSD symptoms |
CRHR1 |
Non-significant |
White, S.,2013
|
rs1876831
|
Post-ICU PTSD |
CRHR1 |
Non-significant |
Davydow, D. S.,2014
|
rs12944712
|
Post-traumatic stress symptoms (PTS) |
CRHR1 |
Non-significant |
Dunn, E. C.,2014
|
rs242941
|
PTSD severity |
CRHR1 |
Non-significant |
Solovieff, N.,2014
|
rs116897693
|
PTSD |
CRHR1 |
Significant |
Nievergelt, C. M.,2015
|
rs110402
|
PTSD symptom severity |
CRHR1 |
Non-significant |
Binder, E. B.,2008
|
rs242924
|
PTSD symptom severity |
CRHR1 |
Non-significant |
Binder, E. B.,2008
|
rs7209436
|
PTSD symptom severity |
CRHR1 |
Non-significant |
Binder, E. B.,2008
|
rs12944712
|
Acute symptoms of PTSD |
CRHR1 |
Significant |
Amstadter, A. B.,2011
|
rs12936181
|
Acute UCLA PTSD-RI score |
CRHR1 |
Non-significant |
Amstadter, A. B.,2011
|
rs12944712
|
Acute UCLA PTSD-RI score |
CRHR1 |
Significant |
Amstadter, A. B.,2011
|
rs17690314
|
Acute UCLA PTSD-RI score |
CRHR1 |
Non-significant |
Amstadter, A. B.,2011
|
rs17763104
|
Acute UCLA PTSD-RI score |
CRHR1 |
Significant |
Amstadter, A. B.,2011
|
rs17763658
|
Acute UCLA PTSD-RI score |
CRHR1 |
Non-significant |
Amstadter, A. B.,2011
|
rs2424942
|
Acute UCLA PTSD-RI score |
CRHR1 |
Non-significant |
Amstadter, A. B.,2011
|
rs4074461
|
Acute UCLA PTSD-RI score |
CRHR1 |
Significant |
Amstadter, A. B.,2011
|
rs4458044
|
Acute UCLA PTSD-RI score |
CRHR1 |
Non-significant |
Amstadter, A. B.,2011
|
rs2190242
|
Latent PTSD Severity |
CRHR2 |
Significant |
Wolf, E. J.,2013
|
rs2267715
|
Latent PTSD Severity |
CRHR2 |
Significant |
Wolf, E. J.,2013
|
rs2284218
|
Latent PTSD Severity |
CRHR2 |
Significant |
Wolf, E. J.,2013
|
rs8192496
|
Latent PTSD Severity |
CRHR2 |
Significant |
Wolf, E. J.,2013
|
rs2190242
|
PTSD diagnosis |
CRHR2 |
Significant |
Wolf, E. J.,2013
|
rs2240404
|
PTSD diagnosis |
CRHR2 |
Significant |
Wolf, E. J.,2013
|
rs2267715
|
PTSD diagnosis |
CRHR2 |
Significant |
Wolf, E. J.,2013
|
rs2267717
|
PTSD diagnosis |
CRHR2 |
Significant |
Wolf, E. J.,2013
|
rs2284216
|
PTSD diagnosis |
CRHR2 |
Significant |
Wolf, E. J.,2013
|
rs2284218
|
PTSD diagnosis |
CRHR2 |
Significant |
Wolf, E. J.,2013
|
rs2284220
|
PTSD diagnosis |
CRHR2 |
Significant |
Wolf, E. J.,2013
|
rs3779250
|
PTSD diagnosis |
CRHR2 |
Significant |
Wolf, E. J.,2013
|
rs8192496
|
PTSD diagnosis |
CRHR2 |
Significant |
Wolf, E. J.,2013
|
rs973002
|
PTSD diagnosis |
CRHR2 |
Significant |
Wolf, E. J.,2013
|
rs1130864
|
PTSD diagnosis |
CRP |
Significant |
Michopoulos, V.,2015
|
rs3091244
|
Current PTSD severity |
CRP |
Non-significant |
Miller, M. W.,2018
|
rs1130864
|
PTSD symptoms |
CRP |
Significant |
Michopoulos, V.,2015
|
rs1205
|
PTSD symptoms |
CRP |
Non-significant |
Michopoulos, V.,2015
|
rs3091244
|
PTSD symptoms |
CRP |
Non-significant |
Michopoulos, V.,2015
|
rs3093066
|
PTSD symptoms |
CRP |
Non-significant |
Michopoulos, V.,2015
|
rs3093067
|
PTSD symptoms |
CRP |
Non-significant |
Michopoulos, V.,2015
|
rs3093068
|
PTSD symptoms |
CRP |
Non-significant |
Michopoulos, V.,2015
|
rs2616978
|
PTSD |
CSMD1 |
Trend |
Nievergelt, C. M.,2015
|
rs142570922
|
PTSD |
CYP11B1 |
Trend |
Nievergelt, C. M.,2015
|
rs1611115
|
Chronic PTSD |
DBH |
Non-significant |
Mustapic, M.,2007
|
rs2073837
|
PTSD diagnosis |
DBH |
Non-significant |
Solovieff, N.,2014
|
rs1076153
|
PTSD severity |
DBH |
Non-significant |
Solovieff, N.,2014
|
rs2519154
|
PTSD |
DBH |
Non-significant |
Nelson, E. C.,2014
|
rs10002308
|
Current PTSD |
DDX60L |
Trend |
Ashley-Koch, A. E.,2015
|
rs9538394
|
Lifetime PTSD |
DIAPH3 |
Trend |
Xie, P.,2013
|
rs71534169
|
Dissociative symptom severity |
DPP6 |
Trend |
Wolf, E. J.,2014
|
rs1800497
|
Reexperiencing of the traumatic events |
DRD2 |
Significant |
Comings, D. E.,1996
|
rs4648317
|
PTSD |
DRD2 |
Non-significant |
Nelson, E. C.,2014
|
rs1800497
|
Total PTSD score |
DRD2 |
Significant |
Comings, D. E.,1996
|
rs6277
|
PTSD |
DRD2 |
Significant |
Voisey, J.,2009
|
rs75924850
|
PTSD |
DRD2 |
Significant |
Nievergelt, C. M.,2015
|
rs1800497
|
Increased hyperreactivity and vigilance |
DRD2 |
Significant |
Comings, D. E.,1996
|
rs1800497
|
PTSD category B symptom score |
DRD2 |
Non-significant |
Bailey, J. N.,2010
|
rs1800497
|
PTSD category C symptom score |
DRD2 |
Non-significant |
Bailey, J. N.,2010
|
rs10891556
|
PTSD diagnosis |
DRD2 |
Non-significant |
Duan, Z.,2015
|
rs1124492
|
PTSD diagnosis |
DRD2 |
Non-significant |
Solovieff, N.,2014
|
rs12574471
|
PTSD diagnosis |
DRD2 |
Non-significant |
Duan, Z.,2015
|
rs1799978
|
PTSD diagnosis |
DRD2 |
Non-significant |
Duan, Z.,2015
|
rs1800479
|
PTSD diagnosis |
DRD2 |
Non-significant |
Duan, Z.,2015
|
rs1800497
|
PTSD diagnosis |
DRD2 |
Significant |
Comings, D. E.,1996
|
rs1800497
|
PTSD diagnosis |
DRD2 |
Non-significant |
Gelernter, J.,1999
|
rs1800497
|
PTSD diagnosis |
DRD2 |
Non-significant |
Bailey, J. N.,2010
|
rs2075652
|
PTSD diagnosis |
DRD2 |
Significant |
Duan, Z.,2015
|
rs2242591
|
PTSD diagnosis |
DRD2 |
Non-significant |
Duan, Z.,2015
|
rs2734833
|
PTSD diagnosis |
DRD2 |
Non-significant |
Duan, Z.,2015
|
rs4436578
|
PTSD diagnosis |
DRD2 |
Significant |
Duan, Z.,2015
|
rs4460839
|
PTSD diagnosis |
DRD2 |
Non-significant |
Duan, Z.,2015
|
rs4586205
|
PTSD diagnosis |
DRD2 |
Non-significant |
Duan, Z.,2015
|
rs4648317
|
PTSD diagnosis |
DRD2 |
Significant |
Duan, Z.,2015
|
rs4648318
|
PTSD diagnosis |
DRD2 |
Non-significant |
Duan, Z.,2015
|
rs4648319
|
PTSD diagnosis |
DRD2 |
Non-significant |
Duan, Z.,2015
|
rs6279
|
PTSD diagnosis |
DRD2 |
Non-significant |
Duan, Z.,2015
|
rs7131056
|
PTSD diagnosis |
DRD2 |
Significant |
Duan, Z.,2015
|
rs4274224
|
PTSD severity |
DRD2 |
Non-significant |
Solovieff, N.,2014
|
DRD2_Taq 1
|
PTSD |
DRD2 |
Significant |
Tian, Y.,2015
|
DRD2_Taq I A alleles
|
PTSD |
DRD2 |
Significant |
Young, R. M.,2002
|
rs12364283
|
PTSD |
DRD2 |
Significant |
Nelson, E. C.,2014
|
rs12805897
|
PTSD |
DRD2 |
Non-significant |
Nelson, E. C.,2014
|
rs10891556 - rs1799978 - rs4648317 - rs7131056 - rs4460839 - rs12574471 - rs4648319 - rs4648318 - rs4586205 - rs4436578 - rs2075652 - rs2734833 - rs6279 - rs2242591 - rs1800479, GTGATCATTTGGCTA
|
PTSD diagnosis |
DRD2 |
Non-significant |
Duan, Z.,2015
|
rs10891556 - rs1799978 - rs4648317 - rs7131056 - rs4460839 - rs12574471 - rs4648319 - rs4648318 - rs4586205 - rs4436578 - rs2075652 - rs2734833 - rs6279 - rs2242591 - rs1800479, GTGATCGCGCAGGCG
|
PTSD diagnosis |
DRD2 |
Significant |
Duan, Z.,2015
|
rs10891556 - rs1799978 - rs4648317 - rs7131056 - rs4460839 - rs12574471 - rs4648319 - rs4648318 - rs4586205 - rs4436578 - rs2075652 - rs2734833 - rs6279 - rs2242591 - rs1800479, TTACTCATTTGGCTA
|
PTSD diagnosis |
DRD2 |
Non-significant |
Duan, Z.,2015
|
rs1800497
|
PTSD symptoms |
DRD2 |
Non-significant |
Bailey, J. N.,2010
|
rs10891556 - rs1799978 - rs4648317 - rs7131056 - rs4460839 - rs12574471 - rs4648319 - rs4648318 - rs4586205 - rs4436578 - rs2075652 - rs2734833 - rs6279 - rs2242591 - rs1800479, TTACTCGCGCAGGCG
|
PTSD diagnosis |
DRD2 |
Non-significant |
Duan, Z.,2015
|
rs1799732
|
PTSD |
DRD2 |
Non-significant |
Voisey, J.,2009
|
rs1800497
|
PTSD |
DRD2 |
Non-significant |
Voisey, J.,2009
|
rs1800497
|
Avoidance of trauma-associated stimuli |
DRD2 |
Significant |
Comings, D. E.,1996
|
rs6787134
|
PTSD |
DRD3 |
Non-significant |
Nelson, E. C.,2014
|
rs201252087
|
PTSD diagnosis |
DRD3 |
Significant |
Wolf, E. J.,2014
|
rs2134655
|
PTSD diagnosis |
DRD3 |
Significant |
Wolf, E. J.,2014
|
rs2251177
|
PTSD diagnosis |
DRD3 |
Significant |
Wolf, E. J.,2014
|
rs4646996
|
PTSD diagnosis |
DRD3 |
Significant |
Wolf, E. J.,2014
|
rs963468
|
PTSD diagnosis |
DRD3 |
Significant |
Wolf, E. J.,2014
|
rs9817063
|
PTSD diagnosis |
DRD3 |
Significant |
Wolf, E. J.,2014
|
rs9868039
|
PTSD diagnosis |
DRD3 |
Significant |
Wolf, E. J.,2014
|
rs4987059
|
PTSD |
DRD4 |
Non-significant |
Nievergelt, C. M.,2015
|
rs7126715
|
PTSD diagnosis |
DRD4 |
Non-significant |
Solovieff, N.,2014
|
rs752306
|
PTSD severity |
DRD4 |
Non-significant |
Solovieff, N.,2014
|
DRD4_exon3_VNTR
|
Avoidance/Numbing symptoms |
DRD4 |
Significant |
Dragan, W. L.,2009
|
DRD4_exon3_VNTR
|
Intrusion/Arousal symptoms |
DRD4 |
Non-significant |
Dragan, W. L.,2009
|
DRD4_exon3_VNTR
|
PTSD-C score |
DRD4 |
Significant |
Dragan, W. L.,2009
|
DRD4_exon3_VNTR
|
PTSD-F score |
DRD4 |
Non-significant |
Dragan, W. L.,2009
|
rs9370822
|
PTSD |
DTNBP1 |
Significant |
Voisey, J.,2010
|
rs9370822
|
PTSD |
DTNBP1 |
Significant |
Voisey, J.,2010
|
rs1011313
|
PTSD diagnosis |
DTNBP1 |
Non-significant |
Solovieff, N.,2014
|
rs3213207
|
PTSD severity |
DTNBP1 |
Non-significant |
Solovieff, N.,2014
|
rs116647843
|
PTSD |
DTNBP1 |
Non-significant |
Nievergelt, C. M.,2015
|
rs2295633
|
Avoidance symptoms |
FAAH |
Non-significant |
Pardini, M.,2012
|
rs324419
|
PTSD |
FAAH |
Non-significant |
Pardini, M.,2012
|
rs324420
|
PTSD |
FAAH |
Non-significant |
Pardini, M.,2012
|
rs3766246
|
PTSD |
FAAH |
Non-significant |
Pardini, M.,2012
|
rs2295633
|
Reexperiencing symptoms |
FAAH |
Significant |
Pardini, M.,2012
|
rs6703669
|
PTSD |
FAAH |
Non-significant |
Pardini, M.,2012
|
rs7524148
|
PTSD |
FAAH |
Non-significant |
Pardini, M.,2012
|
rs913168
|
PTSD |
FAAH |
Non-significant |
Pardini, M.,2012
|
rs324420
|
PTSD symptoms |
FAAH |
Non-significant |
Spagnolo, P. A.,2016
|
rs324420
|
PTSD hyperarousal symptoms |
FAAH |
Significant |
Spagnolo, P. A.,2016
|
rs324420
|
PTSD re-experiencing symptoms |
FAAH |
Non-significant |
Spagnolo, P. A.,2016
|
rs324420
|
PTSD avoidance symptoms |
FAAH |
Non-significant |
Spagnolo, P. A.,2016
|
rs2295633
|
PTSD |
FAAH |
Significant |
Pardini, M.,2012
|
rs2295633
|
Arousal symptoms |
FAAH |
Non-significant |
Pardini, M.,2012
|
rs16904179
|
Lifetime PTSD |
FAM49B |
Trend |
Xie, P.,2013
|
rs6681010
|
PTSD |
FASLG |
Trend |
Nievergelt, C. M.,2015
|
rs2572096
|
Lifetime PTSD |
FBXL4 |
Trend |
Xie, P.,2013
|
rs1360780
|
Improvement in CAPS PTSD symptoms scores |
FKBP5 |
Significant |
David, A. C.,2012
|
rs3800373
|
Improvement in CAPS PTSD symptoms scores |
FKBP5 |
Significant |
David, A. C.,2012
|
rs9296158
|
Improvement in CAPS PTSD symptoms scores |
FKBP5 |
Significant |
David, A. C.,2012
|
rs9366890
|
PTSD |
FKBP5 |
Significant |
Nievergelt, C. M.,2015
|
rs9470080
|
Improvement in CAPS PTSD symptoms scores |
FKBP5 |
Non-significant |
David, A. C.,2012
|
rs9296158
|
PTSD (Total PCL-C score) |
FKBP5 |
Significant |
Kohrt, B. A.,2015
|
rs1360780
|
Lifetime PTSD |
FKBP5 |
Significant |
Xie, P.,2010
|
rs3800373
|
Lifetime PTSD symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs9296158
|
Lifetime PTSD symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs1360780
|
Lifetime PTSD symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs9470080
|
Lifetime PTSD symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs3800373
|
Re-experiencing symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs9296158
|
Re-experiencing symptoms |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs1360780
|
Re-experiencing symptoms |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs9470080
|
Re-experiencing symptoms |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs3800373
|
Lifetime PTSD |
FKBP5 |
Significant |
Xie, P.,2010
|
rs3800373
|
Avoidance symptoms (DSM-IV) |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs9296158
|
Avoidance symptoms (DSM-IV) |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs1360780
|
Avoidance symptoms (DSM-IV) |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs9470080
|
Avoidance symptoms (DSM-IV) |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs3800373
|
Emotional numbing |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs9296158
|
Emotional numbing |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs1360780
|
Emotional numbing |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs9470080
|
Emotional numbing |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs3800373
|
Hyperarousal symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs9296158
|
Hyperarousal symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs1360780
|
Hyperarousal symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs9470080
|
Hyperarousal symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs3800373
|
Intrusion symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs9296158
|
Intrusion symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs1360780
|
Intrusion symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs9470080
|
Intrusion symptoms |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs9296158
|
Lifetime PTSD |
FKBP5 |
Significant |
Xie, P.,2010
|
rs3800373
|
Avoidance symptoms (DSM-5) |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs9470080
|
Lifetime PTSD |
FKBP5 |
Significant |
Xie, P.,2010
|
rs9296158
|
Avoidance symptoms (DSM-5) |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs1360780
|
Avoidance symptoms (DSM-5) |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs9470080
|
Avoidance symptoms (DSM-5) |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs3800373
|
Negative alterations in cognitions and mood symptoms |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs1360780
|
M.I.N.I. suicidality score |
FKBP5 |
Non-significant |
Wilker, S.,2014
|
rs9296158
|
Negative alterations in cognitions and mood symptoms |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs1360780
|
Memory Performance |
FKBP5 |
Non-significant |
David, A. C.,2012
|
rs1360780
|
Negative alterations in cognitions and mood symptoms |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs3800373
|
Memory Performance |
FKBP5 |
Non-significant |
David, A. C.,2012
|
rs9470080
|
Negative alterations in cognitions and mood symptoms |
FKBP5 |
Non-significant |
Watkins, L. E.,2016
|
rs9296158
|
Memory Performance |
FKBP5 |
Non-significant |
David, A. C.,2012
|
rs3800373
|
Alterations in arousal and reactivity symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs9470080
|
Memory Performance |
FKBP5 |
Non-significant |
David, A. C.,2012
|
rs9296158
|
Alterations in arousal and reactivity symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs1360780
|
Alterations in arousal and reactivity symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs9470080
|
Alterations in arousal and reactivity symptoms |
FKBP5 |
Significant |
Watkins, L. E.,2016
|
rs1360780
|
PDS avoidance score |
FKBP5 |
Non-significant |
Wilker, S.,2014
|
rs1360780
|
PDS hyperarousal score |
FKBP5 |
Non-significant |
Wilker, S.,2014
|
rs1360780
|
PDS intrusion score |
FKBP5 |
Non-significant |
Wilker, S.,2014
|
rs1360780
|
PDS score |
FKBP5 |
Non-significant |
Wilker, S.,2014
|
rs1360780
|
Post Traumatic Growth (PTG) |
FKBP5 |
Significant |
Dunn, E. C.,2014
|
rs9296158
|
Post Traumatic Growth (PTG) |
FKBP5 |
Significant |
Dunn, E. C.,2014
|
rs9470080
|
Post Traumatic Growth (PTG) |
FKBP5 |
Significant |
Dunn, E. C.,2014
|
rs2766581
|
PTSD diagnosis |
FKBP5 |
Non-significant |
Solovieff, N.,2014
|
rs1360780
|
Post-traumatic stress symptoms (PTS) |
FKBP5 |
Non-significant |
Dunn, E. C.,2014
|
rs9296158
|
Post-traumatic stress symptoms (PTS) |
FKBP5 |
Non-significant |
Dunn, E. C.,2014
|
rs9470080
|
Post-traumatic stress symptoms (PTS) |
FKBP5 |
Non-significant |
Dunn, E. C.,2014
|
rs1360780
|
PTSD Diagnostic Status at T2 |
FKBP5 |
Significant |
David, A. C.,2012
|
rs3800373
|
PTSD Diagnostic Status at T2 |
FKBP5 |
Significant |
David, A. C.,2012
|
rs9296158
|
PTSD Diagnostic Status at T2 |
FKBP5 |
Significant |
David, A. C.,2012
|
rs9470080
|
PTSD Diagnostic Status at T2 |
FKBP5 |
Significant |
David, A. C.,2012
|
rs276651
|
PTSD severity |
FKBP5 |
Non-significant |
Solovieff, N.,2014
|
rs1334894
|
PTSD Symptoms (PSS scores) |
FKBP5 |
Non-significant |
Binder, E. B.,2008
|
rs1360780
|
PTSD Symptoms (PSS scores) |
FKBP5 |
Non-significant |
Binder, E. B.,2008
|
rs3800373
|
PTSD Symptoms (PSS scores) |
FKBP5 |
Non-significant |
Binder, E. B.,2008
|
rs4713916
|
PTSD Symptoms (PSS scores) |
FKBP5 |
Non-significant |
Binder, E. B.,2008
|
rs737054
|
PTSD Symptoms (PSS scores) |
FKBP5 |
Non-significant |
Binder, E. B.,2008
|
rs9296158
|
PTSD Symptoms (PSS scores) |
FKBP5 |
Non-significant |
Binder, E. B.,2008
|
rs9470080
|
PTSD Symptoms (PSS scores) |
FKBP5 |
Non-significant |
Binder, E. B.,2008
|
rs992105
|
PTSD Symptoms (PSS scores) |
FKBP5 |
Non-significant |
Binder, E. B.,2008
|
rs78826942
|
PTSD |
FRMD5 |
Trend |
Nievergelt, C. M.,2015
|
rs2779551
|
Lifetime PTSD |
GABBR2 |
Trend |
Xie, P.,2013
|
rs693547
|
PTSD diagnosis |
GABRA2 |
Non-significant |
Solovieff, N.,2014
|
rs17537141
|
PTSD severity |
GABRA2 |
Non-significant |
Solovieff, N.,2014
|
rs148139959
|
PTSD |
GABRA2 |
Significant |
Nievergelt, C. M.,2015
|
rs12592749
|
PTSD |
GABRG3 |
Non-significant |
Nelson, E. C.,2014
|
rs7076096
|
Lifetime PTSD |
GRIN1 |
Trend |
Xie, P.,2013
|
rs3859123
|
PTSD |
GRIN2A |
Non-significant |
Nelson, E. C.,2014
|
rs7200719
|
PTSD |
GRIN2A |
Non-significant |
Nelson, E. C.,2014
|
rs9933111
|
PTSD |
GRIN2A |
Non-significant |
Nelson, E. C.,2014
|
rs10845847
|
PTSD |
GRIN2B |
Non-significant |
Nelson, E. C.,2014
|
rs1611133
|
PTSD |
HLA-G3 |
Trend |
Guffanti, G.,2013
|
rs6295
|
PTSD diagnosis |
HTR1A |
Non-significant |
Donaldson, Z. R.,2016
|
rs6311
|
PTSD |
HTR2A |
Significant |
Mellman, T. A.,2009
|
rs6314
|
PTSD |
HTR2A |
Significant |
Nievergelt, C. M.,2015
|
rs10507545
|
PTSD diagnosis |
HTR2A |
Non-significant |
Solovieff, N.,2014
|
rs9534507
|
PTSD severity |
HTR2A |
Non-significant |
Solovieff, N.,2014
|
rs1143643
|
PTSD diagnosis |
IL1B |
Non-significant |
Hovhannisyan, L.,2017
|
rs1143634
|
PTSD diagnosis |
IL1B |
Non-significant |
Hovhannisyan, L.,2017
|
rs1143633
|
PTSD diagnosis |
IL1B |
Significant |
Hovhannisyan, L.,2017
|
rs2853550
|
PTSD diagnosis |
IL1B |
Non-significant |
Hovhannisyan, L.,2017
|
rs16944
|
PTSD diagnosis |
IL1B |
Significant |
Hovhannisyan, L.,2017
|
rs6602398
|
Current PTSD |
IL2RA |
Significant |
Powers, A.,2016
|
rs10768747
|
Current PTSD |
Intergenic |
Trend |
Ashley-Koch, A. E.,2015
|
rs1116255
|
Current PTSD |
Intergenic |
Trend |
Ashley-Koch, A. E.,2015
|
rs17504106
|
Current PTSD |
Intergenic |
Trend |
Ashley-Koch, A. E.,2015
|
rs2862383
|
Current PTSD |
Intergenic |
Trend |
Ashley-Koch, A. E.,2015
|
rs61793204
|
Current PTSD |
Intergenic |
Trend |
Ashley-Koch, A. E.,2015
|
rs834811
|
Current PTSD |
Intergenic |
Trend |
Ashley-Koch, A. E.,2015
|
rs10502692
|
PTSD |
Intergenic |
Trend |
Guffanti, G.,2013
|
rs265983
|
PTSD |
Intergenic |
Non-significant |
Nelson, E. C.,2014
|
rs6080152
|
PTSD Symptoms as measured by the quantitave CAPS scores |
Intergenic (approx distance to downstream gene: 1065kb, PCSK2) |
Trend |
Almli, L. M.,2015
|
rs4239715
|
PTSD Symptoms as measured by the quantitave CAPS scores |
Intergenic (approx distance to downstream gene: 1069kb, PCSK2) |
Trend |
Almli, L. M.,2015
|
rs6080131
|
PTSD Symptoms as measured by the quantitave CAPS scores |
Intergenic (approx distance to downstream gene: 1101kb, PCSK2) |
Trend |
Almli, L. M.,2015
|
rs13113036
|
PTSD Symptoms as measured by the quantitave CAPS scores |
Intergenic (approx distance to downstream gene: 2148kb, DTHD1) |
Trend |
Almli, L. M.,2015
|
rs13104973
|
PTSD Symptoms as measured by the quantitave CAPS scores |
Intergenic (approx distance to downstream gene: 2472kb, DTHD1) |
Trend |
Almli, L. M.,2015
|
rs7684329
|
PTSD Symptoms as measured by the quantitave CAPS scores |
Intergenic (approx distance to downstream gene: 2536kb, DTHD1) |
Trend |
Almli, L. M.,2015
|
rs717947
|
PTSD Symptoms as measured by the quantitave CAPS scores |
Intergenic (approx distance to downstream gene: 2629kb, DTHD1) |
Significant |
Almli, L. M.,2015
|
rs3181035
|
PTSD Symptoms as measured by the quantitave CAPS scores |
Intergenic (approx distance to downstream gene: 458kb, RAP1B) |
Trend |
Almli, L. M.,2015
|
rs17104851
|
PTSD Symptoms as measured by the quantitave CAPS scores |
Intergenic (approx distance to downstream gene: 473kb, RAP1B) |
Trend |
Almli, L. M.,2015
|
rs77963519
|
Dissociative symptom severity |
Intergenic (Closest gene is MEX3B) |
Trend |
Wolf, E. J.,2014
|
rs9725031
|
Dissociative symptom severity |
Intergenic (Closest gene is SIPA1L2) |
Trend |
Wolf, E. J.,2014
|
rs77006546
|
Dissociative symptom severity |
Intergenic (Near CMAHP) |
Trend |
Wolf, E. J.,2014
|
rs7604404
|
PTSD |
ITGA6 |
Non-significant |
Nelson, E. C.,2014
|
rs4916008
|
PTSD |
JAK1 |
Trend |
Nievergelt, C. M.,2015
|
rs2471320
|
PTSD |
JHDM1D-AS1 |
Trend |
Nievergelt, C. M.,2015
|
rs1915919
|
Dissociative symptom severity |
KAT2B |
Trend |
Wolf, E. J.,2014
|
rs79485117
|
PTSD |
KDM7A |
Trend |
Nievergelt, C. M.,2015
|
rs2460905
|
Dissociative symptom severity |
KIAA1456 |
Trend |
Wolf, E. J.,2014
|
rs2466273
|
Dissociative symptom severity |
KIAA1456 |
Trend |
Wolf, E. J.,2014
|
rs62488971
|
Dissociative symptom severity |
KIAA1456 |
Trend |
Wolf, E. J.,2014
|
rs2273816
|
PTSD |
KPNA3 |
Non-significant |
Morris, C. P.,2012
|
rs2413187
|
PTSD |
LARGE |
Trend |
Guffanti, G.,2013
|
rs3100127
|
PTSD |
LGR6 |
Trend |
Nievergelt, C. M.,2015
|
rs4838092
|
PTSD |
LHX2 |
Trend |
Nievergelt, C. M.,2015
|
rs9545302
|
PTSD |
LINC01080 |
Trend |
Nievergelt, C. M.,2015
|
rs10170218
|
Current PTSD |
LINC01090 |
Non-significant |
Ashley-Koch, A. E.,2015
|
rs6759539
|
PTSD |
LINC01090 |
Significant |
Nievergelt, C. M.,2015
|
rs10511822
|
PTSD |
LINGO2 |
Trend |
Nievergelt, C. M.,2015
|
rs12232346
|
Current PTSD |
LOC101928174 |
Trend |
Ashley-Koch, A. E.,2015
|
rs1380630
|
PTSD |
LOC729307 |
Trend |
Nievergelt, C. M.,2015
|
rs62275374
|
PTSD |
LRPAP1 |
Trend |
Nievergelt, C. M.,2015
|
rs11767398
|
PTSD |
LSMEM1 |
Trend |
Guffanti, G.,2013
|
rs6528940
|
PTSD |
MAGEC1 |
Trend |
Nievergelt, C. M.,2015
|
MAOA-uVNTR
|
PTSD symptom severity |
MAOA |
Non-significant |
Svob Strac, D.,2016
|
MAOA-uVNTR
|
PTSD symptoms |
MAOA |
Non-significant |
Svob Strac, D.,2016
|
rs1799836
|
PTSD symptom severity |
MAOB |
Significant |
Svob Strac, D.,2016
|
rs1799836
|
PTSD symptoms |
MAOB |
Non-significant |
Svob Strac, D.,2016
|
MAO-B_intron 13
|
PTSD |
MAOB |
Non-significant |
Pivac, N.,2007
|
rs682457
|
Dissociative symptom severity |
MIR3166 |
Trend |
Wolf, E. J.,2014
|
rs28358884
|
PTSD status |
MT-ATP8 |
Trend |
Flaquer, A.,2015
|
rs28397767
|
PTSD status |
MT-ND5 |
Trend |
Flaquer, A.,2015
|
rs16907840
|
Lifetime PTSD |
MTRNR2L5 |
Trend |
Xie, P.,2013
|
rs6589363
|
PTSD |
NCAM1 |
Non-significant |
Nelson, E. C.,2014
|
rs1245119
|
PTSD |
NCAM1 |
Non-significant |
Nelson, E. C.,2014
|
rs2272651
|
Lifetime PTSD |
NDRG1 |
Trend |
Xie, P.,2013
|
rs6779753
|
PTSD diagnosis |
NLGN1 |
Significant |
Kilaru, V.,2016
|
rs4894661
|
PTSD diagnosis |
NLGN1 |
Significant |
Kilaru, V.,2016
|
rs9658570
|
CAPS score |
NOS1 |
Non-significant |
Bruenig, D.,2017(b)
|
rs1353939
|
CAPS score |
NOS1 |
Non-significant |
Bruenig, D.,2017(b)
|
rs7959232
|
CAPS score |
NOS1 |
Non-significant |
Bruenig, D.,2017(b)
|
rs816353
|
CAPS score |
NOS1 |
Non-significant |
Bruenig, D.,2017(b)
|
rs2291908
|
CAPS score |
NOS1 |
Non-significant |
Bruenig, D.,2017(b)
|
rs11068428
|
CAPS score |
NOS1 |
Non-significant |
Bruenig, D.,2017(b)
|
rs3825102
|
CAPS score |
NOS1 |
Non-significant |
Bruenig, D.,2017(b)
|
rs10744891
|
CAPS score |
NOS1 |
Significant |
Bruenig, D.,2017(b)
|
rs532967
|
CAPS score |
NOS1 |
Non-significant |
Bruenig, D.,2017(b)
|
rs11068445
|
CAPS score |
NOS1 |
Non-significant |
Bruenig, D.,2017(b)
|
rs7295972
|
CAPS score |
NOS1 |
Non-significant |
Bruenig, D.,2017(b)
|
rs549098
|
CAPS score |
NOS1 |
Non-significant |
Bruenig, D.,2017(b)
|
rs2077171
|
CAPS score |
NOS1 |
Non-significant |
Bruenig, D.,2017(b)
|
rs474523
|
CAPS score |
NOS1 |
Non-significant |
Bruenig, D.,2017(b)
|
rs482555
|
CAPS score |
NOS1 |
Non-significant |
Bruenig, D.,2017(b)
|
rs61938733
|
CAPS score |
NOS1 |
Non-significant |
Bruenig, D.,2017(b)
|
rs1337062
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs10918671
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs12074902
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs347300
|
PTSD |
NOS1AP |
Non-significant |
Lawford, B. R.,2013
|
rs1415259
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs347313
|
PTSD |
NOS1AP |
Non-significant |
Lawford, B. R.,2013
|
rs10494366
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs16857031
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs12029454
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs4657178
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs386231
|
PTSD |
NOS1AP |
Significant |
Lawford, B. R.,2013
|
rs10458392
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs10753789
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs10800465
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs4531275
|
PTSD |
NOS1AP |
Non-significant |
Lawford, B. R.,2013
|
rs1572495
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs164148
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs4656355
|
PTSD |
NOS1AP |
Non-significant |
Lawford, B. R.,2013
|
rs4657154
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs4657178
|
PTSD |
NOS1AP |
Non-significant |
Lawford, B. R.,2013
|
rs4526593
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs4657164
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs449908
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs16857019
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs945708
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs10918762
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs10918936
|
CAPS score |
NOS1AP |
Significant |
Bruenig, D.,2017(b)
|
rs10919025
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs12116744
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs12027674
|
CAPS score |
NOS1AP |
Significant |
Bruenig, D.,2017(b)
|
rs12122048
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs7546353
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs7528328
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs3897374
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs6676737
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs6683968
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs6677052
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs6659953
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs6677529
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs12742393
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs10157390
|
CAPS score |
NOS1AP |
Significant |
Bruenig, D.,2017(b)
|
rs2819316
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs2819322
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs9661075
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs347300
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs347311
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs6683968
|
PTSD |
NOS1AP |
Non-significant |
Lawford, B. R.,2013
|
rs347282
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs111479527
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs6704393
|
PTSD |
NOS1AP |
Non-significant |
Lawford, B. R.,2013
|
rs115298183
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs17460657
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs12725553
|
CAPS score |
NOS1AP |
Significant |
Bruenig, D.,2017(b)
|
rs6700867
|
CAPS score |
NOS1AP |
Non-significant |
Bruenig, D.,2017(b)
|
rs945706
|
PTSD |
NOS1AP |
Non-significant |
Lawford, B. R.,2013
|
rs386231
|
Mississippi scores |
NOS1AP |
Significant |
Lawford, B. R.,2013
|
rs1415259
|
PTSD |
NOS1AP |
Non-significant |
Lawford, B. R.,2013
|
rs1415263
|
PTSD |
NOS1AP |
Non-significant |
Lawford, B. R.,2013
|
rs451275 - rs386231, CA
|
PTSD |
NOS1AP |
Non-significant |
Lawford, B. R.,2013
|
rs451275 - rs386231, CG
|
PTSD |
NOS1AP |
Significant |
Lawford, B. R.,2013
|
rs451275 - rs386231, TA
|
PTSD |
NOS1AP |
Non-significant |
Lawford, B. R.,2013
|
rs451275 - rs386231, TG
|
PTSD |
NOS1AP |
Non-significant |
Lawford, B. R.,2013
|
rs1858232
|
PTSD |
NOS1AP |
Non-significant |
Lawford, B. R.,2013
|
rs2341744
|
PTSD |
NOS1AP |
Non-significant |
Lawford, B. R.,2013
|
rs16472
|
PTSD diagnosis |
NPY |
Non-significant |
Solovieff, N.,2014
|
rs16472
|
PTSD severity |
NPY |
Non-significant |
Solovieff, N.,2014
|
rs41423247
|
PTSD |
NR3C1 |
Significant |
Lian, Y.,2014
|
rs79590198
|
PTSD |
NR3C1 |
Non-significant |
Nievergelt, C. M.,2015
|
rs7701443
|
PTSD diagnosis |
NR3C1 |
Non-significant |
Solovieff, N.,2014
|
rs10482605
|
PTSD |
NR3C1 |
Non-significant |
Lian, Y.,2014
|
rs7701443
|
PTSD severity |
NR3C1 |
Non-significant |
Solovieff, N.,2014
|
GR_exon 2_N363S
|
PTSD diagnosis |
NR3C1 |
Non-significant |
Bachmann, A. W.,2005
|
GR_exon_R23K
|
PTSD diagnosis |
NR3C1 |
Non-significant |
Bachmann, A. W.,2005
|
GR_intron 2_Bcl1
|
PTSD diagnosis |
NR3C1 |
Non-significant |
Bachmann, A. W.,2005
|
GR_intron 2_Bcl1
|
PTSD stress symptom scores |
NR3C1 |
Significant |
Hauer, D.,2011
|
rs258747
|
PTSD |
NR3C1 |
Significant |
Lian, Y.,2014
|
rs12147956
|
PTSD |
NRXN3 |
Non-significant |
Nelson, E. C.,2014
|
rs2305272
|
Lifetime PTSD |
NTM |
Trend |
Xie, P.,2013
|
rs6681483
|
PTSD symptoms |
OR11L1 |
Trend |
Melroy-Greif, W. E.,2017
|
rs6667389
|
PTSD symptoms |
OR11L1 |
Trend |
Melroy-Greif, W. E.,2017
|
rs10888255
|
PTSD symptoms |
OR11L1 |
Trend |
Melroy-Greif, W. E.,2017
|
rs10888257
|
PTSD symptoms |
OR11L1 |
Trend |
Melroy-Greif, W. E.,2017
|
rs10888256
|
PTSD symptoms |
OR11L1 |
Trend |
Melroy-Greif, W. E.,2017
|
rs4607924
|
PTSD symptoms |
OR11L1 |
Trend |
Melroy-Greif, W. E.,2017
|
rs151319968
|
PTSD symptoms |
OR2L13 |
Trend |
Melroy-Greif, W. E.,2017
|
rs4491792
|
Lifetime PTSD |
OTOR |
Trend |
Xie, P.,2013
|
rs2254298
|
Post Traumatic Growth (PTG) |
OXTR |
Non-significant |
Dunn, E. C.,2014
|
rs53576
|
Post Traumatic Growth (PTG) |
OXTR |
Non-significant |
Dunn, E. C.,2014
|
rs2254298
|
Post-traumatic stress symptoms (PTS) |
OXTR |
Non-significant |
Dunn, E. C.,2014
|
rs53576
|
Post-traumatic stress symptoms (PTS) |
OXTR |
Non-significant |
Dunn, E. C.,2014
|
rs2236805
|
Lifetime PTSD |
PAX7 |
Trend |
Xie, P.,2013
|
rs2576573
|
PTSD diagnosis |
PENK |
Non-significant |
Solovieff, N.,2014
|
rs2576573
|
PTSD severity |
PENK |
Significant |
Solovieff, N.,2014
|
rs73220799
|
PTSD |
PLXNC1 |
Trend |
Nievergelt, C. M.,2015
|
rs2312236
|
PTSD |
POGK |
Trend |
Nievergelt, C. M.,2015
|
rs148952004
|
PTSD |
PPM1N |
Trend |
Nievergelt, C. M.,2015
|
rs4790904
|
Avoidance symptoms |
PRKCA |
Significant |
de Quervain, D. J.,2012
|
rs4790904
|
Reexperiencing symptoms |
PRKCA |
Significant |
de Quervain, D. J.,2012
|
rs4790904
|
PTSD |
PRKCA |
Significant |
de Quervain, D. J.,2012
|
rs4790904
|
Total PTSD symptoms |
PRKCA |
Significant |
Liu, Y.,2013
|
rs4790904
|
Hyperarousal symptoms |
PRKCA |
Significant |
de Quervain, D. J.,2012
|
rs4790904
|
PTSD category B symptom score |
PRKCA |
Significant |
Liu, Y.,2013
|
rs4790904
|
PTSD category C symptom score |
PRKCA |
Significant |
Liu, Y.,2013
|
rs4790904
|
PTSD category D symptom score |
PRKCA |
Significant |
Liu, Y.,2013
|
rs7207499
|
Lifetime PTSD |
PRKCA |
Trend |
Xie, P.,2013
|
rs4790904
|
PTSD diagnosis |
PRKCA |
Significant |
Liu, Y.,2013
|
rs10762479
|
Current PTSD |
PRKG1 |
Trend |
Ashley-Koch, A. E.,2015
|
rs4701170
|
PTSD |
PRPF31 |
Trend |
Guffanti, G.,2013
|
rs6482463
|
Current PTSD |
PRTFDC1 |
Non-significant |
Ashley-Koch, A. E.,2015
|
rs6482463
|
PTSD |
PRTFDC1 |
Significant |
Nievergelt, C. M.,2015
|
rs1033962
|
PTSD |
PRTFDC1 |
Significant |
Nievergelt, C. M.,2015
|
rs2148269
|
PTSD |
PRTFDC1 |
Trend |
Nievergelt, C. M.,2015
|
rs199563271
|
PTSD |
PTPRT |
Trend |
Nievergelt, C. M.,2015
|
rs4511180
|
PTSD |
PTPRVP |
Trend |
Nievergelt, C. M.,2015
|
rs4606
|
Lifetime PTSD symptoms |
RGS2 |
Non-significant |
Amstadter, A. B.,2009
|
rs4606
|
Post Traumatic Growth (PTG) |
RGS2 |
Significant |
Dunn, E. C.,2014
|
rs4606
|
Post-hurricane PTSD symptoms |
RGS2 |
Non-significant |
Amstadter, A. B.,2009
|
rs6650088
|
PTSD diagnosis |
RGS2 |
Non-significant |
Solovieff, N.,2014
|
rs4606
|
Post-traumatic stress symptoms (PTS) |
RGS2 |
Non-significant |
Dunn, E. C.,2014
|
rs2746073
|
PTSD severity |
RGS2 |
Non-significant |
Solovieff, N.,2014
|
rs141129523
|
PTSD |
RGS2 |
Significant |
Nievergelt, C. M.,2015
|
rs10737854
|
PTSD |
RGS7 |
Trend |
Nievergelt, C. M.,2015
|
rs4775301
|
PTSD |
RORA |
Trend |
Logue, M. W.,2013
|
rs8042149
|
Current PTSD |
RORA |
Non-significant |
Ashley-Koch, A. E.,2015
|
rs8042149
|
PTSD symptom severity |
RORA |
Non-significant |
Cao, C.,2017
|
rs893290
|
High versus low posttraumatic stress trajectory |
RORA |
Significant |
Lowe, S. R.,2015
|
rs8024133
|
PTSD |
RORA |
Trend |
Logue, M. W.,2013
|
rs8041061
|
PTSD |
RORA |
Trend |
Logue, M. W.,2013
|
rs8042149
|
PTSD |
RORA |
Significant |
Logue, M. W.,2013
|
rs893290
|
PTSD |
RORA |
Non-significant |
Logue, M. W.,2013
|
rs16942660
|
Increasing versus decreasing posttraumatic stress trajectory |
RORA |
Significant |
Lowe, S. R.,2015
|
rs11071561
|
PTSD |
RORA |
Trend |
Logue, M. W.,2013
|
rs11071587
|
PTSD |
RORA |
Non-significant |
Logue, M. W.,2013
|
rs11071588
|
PTSD |
RORA |
Trend |
Logue, M. W.,2013
|
rs12442490
|
PTSD |
RORA |
Significant |
Nievergelt, C. M.,2015
|
rs16942660
|
PTSD |
RORA |
Non-significant |
Logue, M. W.,2013
|
rs7158872
|
Lifetime PTSD |
RPS29 |
Trend |
Xie, P.,2013
|
rs2437772
|
Current PTSD |
SDC2 |
Trend |
Ashley-Koch, A. E.,2015
|
rs115028822
|
PTSD |
SERAC1 |
Trend |
Nievergelt, C. M.,2015
|
rs6589574
|
Lifetime PTSD |
SIK3 |
Trend |
Xie, P.,2013
|
rs7208505
|
PTSD diagnosis |
SKA2 |
Non-significant |
Sadeh, N.,2016
|
rs7208505
|
PTSD symptoms |
SKA2 |
Non-significant |
Sadeh, N.,2016
|
rs363238
|
PTSD |
SLC18A2 |
Significant |
Nievergelt, C. M.,2015
|
rs363276
|
PTSD diagnosis |
SLC18A2 |
Significant |
Solovieff, N.,2014
|
rs363276
|
PTSD severity |
SLC18A2 |
Non-significant |
Solovieff, N.,2014
|
rs10082463 - rs2015586 - rs363223 - rs363256 - rs363230 - rs363272 - rs2244249 - rs363276 - rs363279, CGGCGGAAG
|
PTSD diagnosis |
SLC18A2 |
Significant |
Solovieff, N.,2014
|
rs13006863
|
Lifetime PTSD |
SLC4A5 |
Trend |
Xie, P.,2013
|
rs2242446
|
Reexperiencing symptoms |
SLC6A2 |
Non-significant |
Pietrzak, R. H.,2015
|
rs2242446
|
Count of anxious arousal symptoms |
SLC6A2 |
Significant |
Pietrzak, R. H.,2015
|
rs2242446
|
Count of avoidance symptoms |
SLC6A2 |
Non-significant |
Pietrzak, R. H.,2015
|
rs2242446
|
Count of dysphoric arousal symptoms |
SLC6A2 |
Non-significant |
Pietrzak, R. H.,2015
|
rs2242446
|
Count of numbing symptoms |
SLC6A2 |
Non-significant |
Pietrzak, R. H.,2015
|
rs2242446
|
Count of reexperiencing symptoms |
SLC6A2 |
Non-significant |
Pietrzak, R. H.,2015
|
rs2242446
|
Dysphoric arousal symptoms |
SLC6A2 |
Non-significant |
Pietrzak, R. H.,2015
|
rs2242446
|
Exaggerated Startle |
SLC6A2 |
Significant |
Pietrzak, R. H.,2015
|
rs2242446
|
Hypervigilance |
SLC6A2 |
Significant |
Pietrzak, R. H.,2015
|
rs2242446
|
Numbing symptoms |
SLC6A2 |
Non-significant |
Pietrzak, R. H.,2015
|
rs2242446
|
PCL total score |
SLC6A2 |
Non-significant |
Pietrzak, R. H.,2015
|
rs2242446
|
Anxious arousal symptoms |
SLC6A2 |
Significant |
Pietrzak, R. H.,2015
|
rs2242446
|
Avoidance symptoms |
SLC6A2 |
Non-significant |
Pietrzak, R. H.,2015
|
rs6869645
|
PTSD |
SLC6A3 |
Non-significant |
Nelson, E. C.,2014
|
rs11564751
|
PTSD diagnosis |
SLC6A3 |
Non-significant |
Solovieff, N.,2014
|
DAT_3'UTR_VNTR
|
PTSD |
SLC6A3 |
Significant |
Valente, N. L.,2011
|
DAT_3'UTR_VNTR
|
PTSD category B symptom score |
SLC6A3 |
Non-significant |
Drury, S. S.,2009
|
rs11564751
|
PTSD severity |
SLC6A3 |
Non-significant |
Solovieff, N.,2014
|
DAT_3'UTR_VNTR
|
PTSD category B symptom score |
SLC6A3 |
Non-significant |
Bailey, J. N.,2010
|
DAT_3'UTR_VNTR
|
PTSD category C symptom score |
SLC6A3 |
Non-significant |
Drury, S. S.,2009
|
DAT_3'UTR_VNTR
|
PTSD category C symptom score |
SLC6A3 |
Non-significant |
Bailey, J. N.,2010
|
DAT_3'UTR_VNTR
|
PTSD category D symptom score |
SLC6A3 |
Significant |
Drury, S. S.,2009
|
DAT_3'UTR_VNTR
|
PTSD diagnosis |
SLC6A3 |
Significant |
Segman, R. H.,2002
|
DAT_3'UTR_VNTR
|
PTSD diagnosis |
SLC6A3 |
Significant |
Drury, S. S.,2009
|
DAT_3'UTR_VNTR
|
PTSD diagnosis |
SLC6A3 |
Non-significant |
Bailey, J. N.,2010
|
DAT_3'UTR_VNTR
|
PTSD diagnosis |
SLC6A3 |
Significant |
Chang, S. C.,2012
|
DAT_3'UTR_VNTR
|
PTSD symptoms |
SLC6A3 |
Significant |
Drury, S. S.,2009
|
DAT_3'UTR_VNTR
|
PTSD symptoms |
SLC6A3 |
Non-significant |
Bailey, J. N.,2010
|
DAT_3'UTR_VNTR-rs27072, nine repeat-C
|
PTSD category B symptom score |
SLC6A3 |
Non-significant |
Drury, S. S.,2013
|
DAT_3'UTR_VNTR-rs27072, nine repeat-C
|
PTSD category C symptom score |
SLC6A3 |
Significant |
Drury, S. S.,2013
|
DAT_3'UTR_VNTR-rs27072, nine repeat-C
|
PTSD category D symptom score |
SLC6A3 |
Significant |
Drury, S. S.,2013
|
DAT_3'UTR_VNTR-rs27072, nine repeat-C
|
PTSD diagnosis |
SLC6A3 |
Significant |
Drury, S. S.,2013
|
DAT_3'UTR_VNTR-rs27072, nine repeat-C
|
PTSD symptoms |
SLC6A3 |
Significant |
Drury, S. S.,2013
|
rs144782362
|
PTSD |
SLC6A3 |
Significant |
Nievergelt, C. M.,2015
|
rs28914827
|
PTSD |
SLC6A4 |
Non-significant |
Nievergelt, C. M.,2015
|
5-HTTLPR
|
PTSD severity |
SLC6A4 |
Non-significant |
Kovacic Petrovic, Z.,2016
|
rs12939390
|
PTSD diagnosis |
SLC6A4 |
Non-significant |
Solovieff, N.,2014
|
5-HTT_intron 2_VNTR
|
PTSD |
SLC6A4 |
Significant |
Zhao, L. S.,2012
|
5-HTTLPR
|
Acute PTSD |
SLC6A4 |
Non-significant |
Thakur, G. A., 2009
|
5-HTTLPR
|
Arousal symptoms |
SLC6A4 |
Non-significant |
Walsh, K.,2014
|
5-HTTLPR
|
Avoidance symptoms |
SLC6A4 |
Non-significant |
Walsh, K.,2014
|
5-HTTLPR
|
CAPS score |
SLC6A4 |
Significant |
Wang, Z.,2011
|
5-HTTLPR
|
Chronic PTSD |
SLC6A4 |
Non-significant |
Thakur, G. A., 2009
|
5-HTTLPR
|
Current diagnosis of PTSD |
SLC6A4 |
Non-significant |
Koenen, K. C.,2009
|
5-HTTLPR
|
Current diagnosis of PTSD |
SLC6A4 |
Significant |
Liu, Y.,2015
|
5-HTTLPR
|
Lifetime PTSD |
SLC6A4 |
Non-significant |
Xie, P.,2009
|
5-HTTLPR
|
Lifetime PTSD |
SLC6A4 |
Significant |
Kolassa, I. T.,2010
|
5-HTTLPR
|
Lifetime PTSD |
SLC6A4 |
Non-significant |
Xie, P.,2012
|
5-HTTLPR
|
Numbing symptoms |
SLC6A4 |
Non-significant |
Walsh, K.,2014
|
5-HTTLPR
|
PCL-M scores |
SLC6A4 |
Significant |
Kimbrel, N. A.,2015
|
5-HTTLPR
|
Post Traumatic Growth (PTG) |
SLC6A4 |
Non-significant |
Dunn, E. C.,2014
|
5-HTTLPR
|
Post-hurricane PTSD |
SLC6A4 |
Non-significant |
Kilpatrick, D. G.,2007
|
5-HTTLPR
|
Postshooting PTSD symptoms score (delta DEQ >1 month) |
SLC6A4 |
Non-significant |
Mercer, K. B.,2012
|
5-HTTLPR
|
Posttraumatic stress (PTS) symptoms 2 years after 9/11 |
SLC6A4 |
Non-significant |
Holman, E. A.,2011
|
5-HTTLPR
|
Posttraumatic stress (PTS) symptoms 3 years after 9/11 |
SLC6A4 |
Non-significant |
Holman, E. A.,2011
|
5-HTTLPR
|
Post-traumatic stress symptoms (PTS) |
SLC6A4 |
Non-significant |
Dunn, E. C.,2014
|
5-HTTLPR
|
PTSD |
SLC6A4 |
Non-significant |
Mellman, T. A.,2009
|
5-HTTLPR
|
PTSD |
SLC6A4 |
Non-significant |
Navarro-Mateu, F.,2013
|
5-HTTLPR
|
PTSD |
SLC6A4 |
Non-significant |
Gressier, F.,2013
|
rs25531
|
Postshooting PTSD symptoms score (delta DEQ >1 month) |
SLC6A4 |
Non-significant |
Mercer, K. B.,2012
|
5-HTTLPR
|
PTSD |
SLC6A4 |
Significant |
Tian, Y.,2015
|
5-HTTLPR
|
PTSD |
SLC6A4 |
Non-significant |
Telch, M. J.,2015
|
5-HTTLPR
|
PTSD |
SLC6A4 |
Non-significant |
Valente, N. L.,2011
|
5-HTTLPR
|
PTSD category B symptom score |
SLC6A4 |
Non-significant |
Grabe, H. J.,2009
|
5-HTTLPR
|
PTSD category C symptom score |
SLC6A4 |
Non-significant |
Grabe, H. J.,2009
|
5-HTTLPR
|
PTSD category D symptom score |
SLC6A4 |
Non-significant |
Grabe, H. J.,2009
|
5-HTTLPR
|
PTSD diagnosis |
SLC6A4 |
Significant |
Grabe, H. J.,2009
|
5-HTTLPR
|
PTSD diagnosis |
SLC6A4 |
Non-significant |
Pietrzak, R. H.,2013
|
5-HTTLPR
|
PTSD severity |
SLC6A4 |
Significant |
Wang, Z.,2011
|
5-HTTLPR
|
PTSD severity |
SLC6A4 |
Significant |
Walsh, K.,2014
|
5-HTTLPR
|
PTSD status |
SLC6A4 |
Significant |
Wang, Z.,2011
|
5-HTTLPR
|
PTSD symptoms |
SLC6A4 |
Non-significant |
La Greca, A. M.,2013
|
5-HTTLPR
|
PTSD-RI (PTSD symptoms) |
SLC6A4 |
Non-significant |
Goenjian, A. K.,2012
|
5-HTTLPR
|
PTSS scores |
SLC6A4 |
Significant |
Olsson, A.,2015
|
5-HTTLPR
|
QOLS scores |
SLC6A4 |
Significant |
Kimbrel, N. A.,2015
|
5-HTTLPR
|
Reexperiencing symptoms |
SLC6A4 |
Non-significant |
Walsh, K.,2014
|
5-HTTLPR
|
Severity of PTSD symptoms |
SLC6A4 |
Non-significant |
Pietrzak, R. H.,2013
|
5-HTTLPR multimarker
|
Postshooting PTSD symptoms score (delta DEQ >1 month) |
SLC6A4 |
Non-significant |
Mercer, K. B.,2012
|
5-HTTVNTR
|
PTSD |
SLC6A4 |
Significant |
Tian, Y.,2015
|
rs12939390
|
PTSD severity |
SLC6A4 |
Non-significant |
Solovieff, N.,2014
|
SERTPR
|
PTSD diagnosis |
SLC6A4 |
Significant |
Lee, H. J.,2005
|
STin2
|
Postshooting PTSD symptoms score (delta DEQ >1 month) |
SLC6A4 |
Non-significant |
Mercer, K. B.,2012
|
rs523349
|
Avoidance/Numbing symptoms |
SRD5A2 |
Significant |
Gillespie, Charles F.,2013
|
rs523349
|
Total PSS score |
SRD5A2 |
Significant |
Gillespie, C. F.,2013
|
rs523349
|
Total PTSD symptoms |
SRD5A2 |
Significant |
Gillespie, Charles F.,2013
|
rs77929608
|
PTSD |
SRD5A2 |
Significant |
Nievergelt, C. M.,2015
|
rs523349
|
Hyperarousal symptoms |
SRD5A2 |
Significant |
Gillespie, Charles F.,2013
|
rs523349
|
Intrusive/Reexperiencing symptoms |
SRD5A2 |
Significant |
Gillespie, Charles F.,2013
|
rs523349
|
PTSD diagnosis |
SRD5A2 |
Significant |
Gillespie, C. F.,2013
|
rs523349
|
Proxy-diagnosis of PTSD |
SRD5A2 |
Significant |
Gillespie, Charles F.,2013
|
rs523349
|
PSS avoidance/numbing subscale |
SRD5A2 |
Significant |
Gillespie, C. F.,2013
|
rs523349
|
PSS hyperarousal subscale |
SRD5A2 |
Significant |
Gillespie, C. F.,2013
|
rs523349
|
PSS intrusive/reexperiencing subscale |
SRD5A2 |
Significant |
Gillespie, C. F.,2013
|
rs182455
|
Reexperiencing symptoms |
STMN1 |
Significant |
Cao, C.,2013
|
rs4659395
|
PTSD |
STMN1 |
Non-significant |
Nievergelt, C. M.,2015
|
rs182455
|
Dysphoric arousal symptoms |
STMN1 |
Non-significant |
Cao, C.,2013
|
rs182455
|
Emotional numbing symptoms |
STMN1 |
Non-significant |
Cao, C.,2013
|
rs182455
|
Anxious arousal symptoms |
STMN1 |
Non-significant |
Cao, C.,2013
|
rs182455
|
Avoidance symptoms |
STMN1 |
Non-significant |
Cao, C.,2013
|
rs7866350
|
Current PTSD |
TBC1D2 |
Trend |
Ashley-Koch, A. E.,2015
|
rs1425392
|
Lifetime PTSD |
TECRL |
Trend |
Xie, P.,2013
|
rs10840490
|
PTSD |
TH |
Non-significant |
Nelson, E. C.,2014
|
rs10840491
|
PTSD |
TH |
Non-significant |
Nelson, E. C.,2014
|
rs6812849
|
Current PTSD |
TLL1 |
Non-significant |
Ashley-Koch, A. E.,2015
|
rs1503292
|
Lifetime PTSD |
TLL1 |
Trend |
Xie, P.,2013
|
rs6812849
|
Lifetime PTSD |
TLL1 |
Significant |
Xie, P.,2013
|
rs7691872
|
Lifetime PTSD |
TLL1 |
Trend |
Xie, P.,2013
|
rs113712660
|
PTSD |
TLL1 |
Significant |
Nievergelt, C. M.,2015
|
rs1503292
|
PTSD symptoms (mPSS) |
TLL1 |
Non-significant |
Almli, L. M.,2014
|
rs6812849
|
PTSD symptoms (mPSS) |
TLL1 |
Non-significant |
Almli, L. M.,2014
|
rs7691872
|
PTSD symptoms (mPSS) |
TLL1 |
Non-significant |
Almli, L. M.,2014
|
rs7302717
|
PTSD |
TMCC3 |
Trend |
Guffanti, G.,2013
|
rs1800629
|
CAPS score |
TNF |
Significant |
Bruenig, D.,2017(a)
|
rs1799913
|
PTSD-RI (PTSD symptoms) |
TPH1 |
Non-significant |
Goenjian, A. K.,2012
|
rs2108977
|
PTSD-RI (PTSD symptoms) |
TPH1 |
Significant |
Goenjian, A. K.,2012
|
rs544437
|
PTSD |
TPH1 |
Non-significant |
Nievergelt, C. M.,2015
|
rs11606304
|
PTSD diagnosis |
TPH1 |
Non-significant |
Solovieff, N.,2014
|
rs11606304
|
PTSD severity |
TPH1 |
Non-significant |
Solovieff, N.,2014
|
rs17794760
|
PTSD |
TPH1 |
Non-significant |
Nelson, E. C.,2014
|
rs11178997
|
PTSD-RI (PTSD symptoms) |
TPH2 |
Significant |
Goenjian, A. K.,2012
|
rs1386494
|
PTSD-RI (PTSD symptoms) |
TPH2 |
Non-significant |
Goenjian, A. K.,2012
|
rs17110747
|
PTSD-RI (PTSD symptoms) |
TPH2 |
Non-significant |
Goenjian, A. K.,2012
|
rs2129575
|
PTSD-RI (PTSD symptoms) |
TPH2 |
Non-significant |
Goenjian, A. K.,2012
|
rs4290270
|
PTSD-RI (PTSD symptoms) |
TPH2 |
Non-significant |
Goenjian, A. K.,2012
|
rs4570625
|
PTSD-RI (PTSD symptoms) |
TPH2 |
Non-significant |
Goenjian, A. K.,2012
|
rs11178997
|
Reexperiencing symptoms |
TPH2 |
Non-significant |
Cao, C.,2014
|
rs11178997
|
Dysphoric arousal symptoms |
TPH2 |
Non-significant |
Cao, C.,2014
|
rs11178997
|
Emotional numbing symptoms |
TPH2 |
Non-significant |
Cao, C.,2014
|
rs17110747
|
PTSD diagnosis |
TPH2 |
Non-significant |
Solovieff, N.,2014
|
rs7300641
|
PTSD severity |
TPH2 |
Non-significant |
Solovieff, N.,2014
|
rs11178997
|
PTSD symptoms |
TPH2 |
Non-significant |
Cao, C.,2014
|
rs183063707
|
PTSD |
TPH2 |
Significant |
Nievergelt, C. M.,2015
|
rs11178997
|
Anxious arousal symptoms |
TPH2 |
Non-significant |
Cao, C.,2014
|
rs11178997
|
Avoidance symptoms |
TPH2 |
Significant |
Cao, C.,2014
|
rs7014900
|
Lifetime PTSD |
TRPS1 |
Trend |
Xie, P.,2013
|
rs187093517
|
PTSD |
UBE2E3 |
Trend |
Nievergelt, C. M.,2015
|
rs138384996
|
PTSD |
UBE2U |
Trend |
Nievergelt, C. M.,2015
|
rs73419609
|
Current PTSD |
UNC13C |
Trend |
Ashley-Koch, A. E.,2015
|
rs11909487
|
Lifetime PTSD |
USP25 |
Trend |
Xie, P.,2013
|
rs10457838
|
PTSD |
UST |
Trend |
Nievergelt, C. M.,2015
|
rs72986828
|
PTSD |
WDR5 |
Trend |
Logue, M. W.,2013
|
rs10038727
|
Current PTSD |
WWC1 |
Significant |
Wilker, S.,2013
|
rs4576167
|
Current PTSD |
WWC1 |
Significant |
Wilker, S.,2013
|
rs10038727
|
Lifetime PTSD |
WWC1 |
Significant |
Sumner, J. A.,2014
|
rs10038727
|
PTSD diagnosis |
WWC1 |
Significant |
Wilker, S.,2013
|
rs10038727
|
PDS hyperarousal score |
WWC1 |
Significant |
Wilker, S.,2013
|
rs4576167
|
PDS hyperarousal score |
WWC1 |
Significant |
Wilker, S.,2013
|
rs10038727
|
PDS intrusion score |
WWC1 |
Significant |
Wilker, S.,2013
|
rs4576167
|
PDS intrusion score |
WWC1 |
Significant |
Wilker, S.,2013
|
rs4576167
|
PTSD diagnosis |
WWC1 |
Significant |
Wilker, S.,2013
|
rs17551315
|
PTSD |
WWC1 |
Significant |
Nievergelt, C. M.,2015
|
rs4955793
|
Lifetime PTSD |
ZMAT3 |
Trend |
Xie, P.,2013
|
rs11085374
|
PTSD diagnosis |
ZNF626 |
Significant |
Stein, M. B.,2016
|